42 results
DEFA14A
AVTX
Avalo Therapeutics Inc
28 Mar 24
Additional proxy soliciting materials
6:26am
Truex satisfies the independence requirements of Rule 5605(a)(2) of the Nasdaq Stock Market listing rules and Rule 10A-3 under the Securities
8-K
AVTX
Avalo Therapeutics Inc
28 Mar 24
Avalo Acquires Anti-IL-1β mAb and Announces Private Placement Financing of up to $185 Million
6:08am
Truex satisfies the independence requirements of Rule 5605(a)(2) of the Nasdaq Stock Market listing rules and Rule 10A-3 under the Securities
8-K
EX-3.1
6y29ms
17 Oct 23
Amendments to Articles of Incorporation or Bylaws
4:02pm
8-K
rn1m 19cx6
6 Dec 21
Avalo Appoints Two New Independent Directors to Its Board
7:41am
8-K
EX-3.2
od5p7r
26 Aug 21
Amendments to Articles of Incorporation or Bylaws
7:47am
8-K
EX-1.1
17pjhe xdct1iyq5lrz
2 Jul 21
Entry into a Material Definitive Agreement
4:15pm
8-K
g5r8 dsb2
13 Oct 20
Cerecor Appoints Gilla Kaplan, Ph.D., to the Board of Directors
6:50am
8-K
gnpwzhmsppc6zfd4
27 Apr 20
Cerecor Announces Changes to Board of Directors
4:01pm
424B5
jz1myu5yceg3e 7ob
4 Feb 20
Prospectus supplement for primary offering
4:46pm